the aid library

World Health Organisation (WHO) (2023) C_WHO

The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform. Guidelines ... more

Download (113)

View PDF (132)

WHO South Sudan Annual Report 2022

World Health Organisation (WHO) (2023) C_WHO

A lot has happened this year. While we continued to tackle the COVID-19 pandemic, we were hit by disease outbreaks and humanitarian crises. Yet, despite these challenges, we marched on, resolute in resolving critical health systems issues to increase access to quality healthcare services. To furth... more

Download (173)

View PDF (192)

WHO framework for meaningful engagement of people living with noncommunicable diseases, and mental health and neurological conditions

World Health Organisation (WHO) (2023) C_WHO

The overall objective of the framework is to support WHO and Members States in meaningful engagement of people living with NCDs, and mental health and neurological conditions to co-create and enhance related policies, programmes and services. This framework will contribute to advancing understanding... more

Cadre de l’OMS pour assurer la participation significative des personnes vivant avec des maladies non transmissibles et des problèmes de santé mentale et neurologiques

World Health Organisation (WHO) (2023) C_WHO

L’objectif général de ce cadre est de permettre à l’OMS et à ses États Membres d’assurer la participation significative des personnes vivant avec des maladies non transmissibles, des problèmes de santé mentale et neurologiques, via un processus de cocréation et de renforcement des poli... more

Préserver la Sécurité sanitaire et servir les populations vulnérables

World Health Organisation (WHO) (2023) C_WHO

Le 13ème programme général de travail (PGT) 2019-2023 de l’OMS va amorcer bientôt sa dernière année de mise en oeuvre. Cependant, le chemin vers l’objectif du « triple milliard » semble encore long, à savoir « faire en sorte qu’un milliard de personnes supplémentaires bénéficient ... more

Download (199)

View PDF (122)

Financing for Sustainable Development Report 2022

Inter-agency Task Force on Financing for Development United Nations (UN) (2022) CC

The 2022 Financing for Sustainable Development Report identifies a “great finance divide” as a main driver of the divergent recovery. Developed countries were able to borrow record sums at ultra-low interest rates to support their people and economies, but the pandemic response and investment in... more

Download (131)

View PDF (140)

Global expenditure on health: Public spending on the rise?

World Health Organisation (WHO) (2021) C_WHO

The 2021 Report examines country health spending patterns and trends over the past 20 years, before the COVID-19 pandemic, with greater focus on public spending on health. The report also presents spending on primary health care, preliminary health expenditure in 2020 for a small set of countries (i... more

Download (171)

View PDF (311)

Infection prevention and control in the context of coronavirus disease (‎COVID-19)‎: a living guideline, 10 August 2023

World Health Organization WHO (2023) C_WHO

The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline... more

Download (162)

View PDF (179)

Clinical management of COVID-19: Living guideline, 18 August 2023

World Health Organisation (WHO) (2023) C_WHO

The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.

Download (246)

View PDF (367)

Infection prevention and control in the context of coronavirus disease (‎COVID-19)‎: a living guideline, 9 October 2023

World Health Organization WHO (2023) CC

Download (287)

View PDF (384)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Global technical consultation report on proposed terminology for pathogens that transmit through the air

World Health Organization WHO (2024) C_WHO

Terminology used to describe the transmission of pathogens through the air varies across scientific disciplines, organizations and the general public. While this has been the case for decades, during the coronavirus disease (COVID-19) pandemic, the terms ‘airborne’, ‘airborne transmission’ a... more

Download (188)

View PDF (222)

Interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19: interim guidance, 20 December 2021

World Health Organization WHO (2022) C_WHO

27 September 2022 These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.

Download (870)

View PDF (1308)

Improving Child Nutrition

Unite for Children; UNICEF (2013)

The achievable imperative for global progress

Download (739)

View PDF (739)

Maximising the Nutritional Impact of Food Security and Livelihoods Interventions: A manual for field workers

Geraldine Le Cuziat, Geraldine; Mattinen, Hanna ACF International (2011) C1

This manual aims to provide practical guidance to field workers in order to maximise the nutritional impact of food security & livelihoods (FSL) interventions. This requires the systematic use of a ‘nutrition lens’ at each step of the project cycle and a close collaboration between sectors.

Download (371)

View PDF (518)

Sierra Leone Food and Nutrition Security Policy Implementation Plan 2012-2016

Government of Sierra Leone (2012) C1

Download (2756)

View PDF (1013)

Namibia: Training of Trainers Manual on School Health

Ministry of Health and Social Services (MOHSS) & Ministry of Education, Arts and Culture (MOEAC) (2015) C1

Download (444)

View PDF (646)

Attraction and Retention of Rural Primary Health-care Workers in the Asia Pacific Region

Liu Xiaoyun; Zhu, Anna; Tang, Shenglan World Health Organization, Regional Office for South-East Asia (2018) C_WHO

The Asia Pacific Observatory on Health Systems and Policies is a collaborative partnership which supports and promotes evidence-based health policy making in the Asia Pacific Region. Based in WHO’s Regional Office for South-East Asia, it brings together governments, international agencies, foundat... more

Download (604)

View PDF (655)

Feeding Practices and Nutritional Status of Children Age 6-23 Months in Myanmar: Further Analysis of the 2015-16 Demographic and Health Survey

Mya, Kyaw Swa, Aung Tin Kyaw, and Thandar Tun The DHS Program (2018) C1

DHS Working Paper No. 136
A total of 1,222 children age 6-23 months were included in this analysis. Twenty percent of children were stunted and 43% were moderately anemic. Regarding IYCF practices, only 16% of children received a minimum acceptable diet, 25% received diverse food groups, 58% were... more

Download (202)

View PDF (298)

Trauma and PTSD in the WHO World Mental Health Surveys

Kessler, R.C., Aguilar-Gaxiola, S., Alonso, J., et al. European of Psychotraumatology (2017) CC

Objective: To review research on associations of trauma type with PTSD in the WHO World Mental Health (WMH) surveys, a series of epidemiological surveys that obtained representative data on trauma-specific PTSD.